For over a decade, improved access has been one of the most significant components of the national healthcare discussion. It’s a sizeable talking point, and it’s tempting to think that securing a doctor’s visit is enough to ensure good health. That assumption is incorrect.
Instead, research shows a variety of other factors, collectively known as social determinants of health (SDOH), play a much more pivotal role in health outcomes. These elements can impact anyone, but the Medicaid population is frequently the most affected. For example, many patients struggle to keep up with regular clinic visits. And missed visits often lead to emergency department (ED) overutilization.
Fortunately, it’s possible to reduce the SDOH effect. A partnership between community health workers (CHW), like Genovista ACO associated with Innovista Health, and payers, like Amerigroup, can help re-route patients to the primary care services they need before they resort to the ED.
SDOH—underlying economic, education, healthcare, environmental, and social factors—profoundly affect a patient’s overall well-being. In fact, 90% of what contributes to an individual’s overall health, including premature death, stems from SDOH. These problems can include:
“SDOH have a big influence over someone’s health condition and situation, particularly for our Medicaid patients,” says Charlonda Thrower, LMSW, MBA-HCM, Innovista Health’s director of Medicaid Programs for the North Texas Market. “In the last three years, four concerns—food, transportation, housing, and childcare—have fluctuated as the top problems for this group.”
It’s well known that poverty contributes to problems that negatively influence health, like lower access to safe neighborhoods, healthy foods, and higher education. Overall, these SDOH contribute to over one-third of total deaths in the United States annually.
Combatting the negative impacts of SDOH requires close collaboration. And CHWs form the backbone of these efforts. To address these challenges, they:
With their in-depth patient knowledge, CHWs at Genovista work with Amerigroup to reach patients who need assistance and help doctors better provide services.
“We communicate with Amerigroup at least monthly to alert them to patients we learn need help through our relationships with their providers. Then we connect those patients with the payer services they need,” Thrower says. “In some cases, Amerigroup is already working with the patient. For newly identified patients, though, they connect them with a variety of programs.”
As a team, the Genovista CHWs use risk stratification to target patients. Then, to gauge progress, they measure primary care provider connectivity and examine the quality of outcomes. In this instance, a drop in ED utilization equals success.
Genovista and Amerigroup tested the power of their partnership in 2020. They detected their patient population’s pre-pandemic ED utilization was nearly 50% higher than Medicaid’s national goal. Based on their analytics, Thrower says they saw the possibility for improvement.
“When our patients present to the ED, roughly nine times out of 10 they are not admitted,” explains Thrower. “That means they didn’t need to be there. Our data identified this discrepancy as an opportunity for our CHWs to directly impact patients going into the ED.”
Using artificial intelligence algorithms, they identified their most frequent ED utilizers from the previous year. Then, everyone went to work. CHWs received alerts about each patient who visited the ED. Within one to three days post-discharge, they contacted patients to complete an SDOH assessment and conduct motivational interviews.
“With motivational interviewing, we encourage the patient to tell us their story in their own words. There’s no blaming or shaming,” Thrower says. “It’s an effort to determine the root cause of their problems and direct them to an alternative to the ED.”
During these conversations, CHWs introduced patients to ED alternatives, including:
If needed, CHWs connected patients with community resources, helped them set up a primary care visit, and followed up with them within a week. As a result, Thrower says, the overall ED utilization fell by nearly 40% within nine months.
Alongside this reduction, Genovista and Amerigroup have identified several positive trends:
This CHW intervention significantly benefited one patient in particular, reducing her outpatient cost and saving her time in the hospital.
In 2021, this patient visited the ED 69 times, not including admissions or readmissions. These encounters carried a hefty $34,305 price tag. To reduce her utilization, Genovista connected her with a CHW.
“Our CHW talked with her and looked at ways to mitigate the SDOH that were at play,” Thrower says. “We identified her needs and resolved the majority of those barriers.”
The CHW directed her to other alternatives for her non-emergent care needs, Community Based Organization referrals, and additional support services from Amerigroup such as Remote Patient Monitoring. As a result, her ED visits plummeted to two unavoidable emergency care encounters in 2022, and the cost dropped to $711.
This outcome showcases the significant shift in healthcare that’s possible when providers, patients, and payers collaborate to combat the SDOH impact.
“What we do is a science and an art. The science is the data that drives us—it tells a story and shows us where we need to target. The art is the human connection; listening to patients talk about their challenges, how they welcome better healthcare for their families,” Thrower says. “It is the power of partnership with our payers, patients, doctors, and [other] stakeholders that we can truly lift the weight of SDOH and bring about change for this population.”